And other news from Christians around the world.

For 14 years, scientists have been growing a tree akin to the Judean balsam — the source of the balm of Gilead — but with no modern counterpart. For 14 years, scientists have been growing a ...

Scientists have resurrected a strange seed that was discovered in a cave in the Judean desert during the 1980s. According to ...

Mt. Gilead earned a convincing 63-40 win over Tree of Life for an Ohio girls basketball victory on Dec. 28. In recent action on Dec. 21, Tree of Life faced off against Cols. Cristo Rey and Mt Gilead ...

hypothesized that Sheba may be an example of the historical “Judean Balsam” or “Balm of Judea”, a tree that was prized for its fragrance during antiquity. This tree was extensively ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Gilead's stock has surged due to successful launches of Livdelzi for PBC and promising developments in lenacapavir for HIV prevention. Livdelzi's approval and strong market potential, combined ...

Gilead Sciences (GILD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Interested in blogging for timesofindia.com? We will be happy to have you on board as a blogger, if you have the knack for writing. Just drop in a mail at [email protected] with a brief ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Co-founder Finny Kuruvilla manages the firm’s largest two funds — Eventide Gilead and Eventide Healthcare and Life Sciences — and remains the firm’s largest owner, though more than 20 of ...